AHR
American Healthcare REIT, Inc. NYSE$50.13
Mkt Cap $9.6B
52w Low $31.94
80.0% of range
52w High $54.67
50d MA $50.25
200d MA $46.22
P/E (TTM)
119.4x
EV/EBITDA
28.8x
P/B
2.5x
Debt/Equity
0.5x
ROE
2.1%
P/FCF
47.1x
RSI (14)
—
ATR (14)
—
Beta
1.18
50d MA
$50.25
200d MA
$46.22
Avg Volume
2.9M
About
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company bene…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | 0.15 | 0.06 | -61.3% | 53.19 | -0.8% | -1.8% | -0.5% | -1.5% | -2.5% | -2.0% | -11.8% | — |
| Nov 6, 2025 | AMC | 0.42 | 0.33 | -21.4% | 47.92 | +1.1% | +3.1% | +3.0% | +2.6% | -0.1% | +0.7% | +4.0% | — |
| Aug 7, 2025 | AMC | 0.40 | 0.06 | -85.0% | 39.86 | +1.4% | +1.6% | +1.3% | +1.7% | +2.0% | +1.3% | +7.3% | — |
| May 8, 2025 | AMC | 0.37 | -0.04 | -110.8% | 32.21 | +1.8% | +8.4% | +7.9% | +7.5% | +6.1% | +8.6% | +9.3% | — |
| Feb 27, 2025 | AMC | 0.40 | -0.21 | -152.5% | 30.18 | -4.4% | -1.3% | +0.9% | +1.2% | +0.7% | -3.8% | +0.4% | — |
| Nov 12, 2024 | AMC | 0.32 | -0.03 | -109.4% | 25.91 | +2.1% | +3.4% | +1.2% | +4.9% | +5.9% | +8.5% | +9.4% | — |
| Aug 5, 2024 | AMC | 0.29 | 0.01 | -96.6% | 15.67 | +4.4% | +6.4% | +4.8% | +6.6% | +6.7% | +9.4% | +39.1% | — |
| May 13, 2024 | AMC | 0.31 | -0.04 | -112.9% | 14.09 | -0.6% | -0.6% | +3.3% | +1.7% | +2.9% | +2.3% | +5.6% | — |
| Mar 21, 2024 | AMC | 0.29 | -0.42 | -244.8% | 14.18 | +1.7% | -1.8% | +2.8% | +2.2% | +1.3% | +4.0% | -6.6% | — |
| Sep 30, 2023 | AMC | — | -0.09 | — | — | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 | Truist | Maintains | Buy → Buy | — | $52.13 | $52.73 | +1.2% | +0.1% | +1.1% | +1.7% | +0.8% | -1.9% |
| Mar 11 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $52.98 | $52.34 | -1.2% | -0.3% | -1.6% | -1.5% | -0.5% | +0.1% |
| Mar 2 | Citigroup | Maintains | Neutral → Neutral | — | $52.24 | $52.24 | +0.0% | +1.3% | +0.2% | -0.7% | -0.2% | -1.4% |
| Feb 5 | Citizens | Maintains | Market Outperform → Market Outperform | — | $46.82 | $46.32 | -1.1% | +2.9% | +4.2% | +5.5% | +7.8% | +10.1% |
| Jan 20 | Truist | Maintains | Buy → Buy | — | $48.01 | $47.44 | -1.2% | -1.3% | +1.3% | -3.2% | -3.7% | -3.7% |
| Nov 26 | Truist | Maintains | Buy → Buy | — | $48.79 | $49.00 | +0.4% | +3.5% | +4.1% | +3.4% | +3.4% | +3.1% |
| Nov 21 | Citigroup | Maintains | Neutral → Neutral | — | $49.23 | $47.76 | -3.0% | -2.5% | -0.9% | -0.9% | +2.6% | +3.1% |
| Nov 20 | Morgan Stanley | Maintains | Overweight → Overweight | — | $49.49 | $49.90 | +0.8% | -0.5% | -3.0% | -1.4% | -1.4% | +2.0% |
| Nov 17 | UBS | Maintains | Buy → Buy | — | $48.32 | $48.60 | +0.6% | -0.8% | +1.7% | +2.4% | +1.9% | -0.7% |
| Nov 13 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $47.87 | $47.83 | -0.1% | +0.8% | +0.9% | +0.1% | +2.7% | +3.4% |
Recent Filings
8-K · 1.01
! Medium
American Healthcare REIT, Inc. -- 8-K 1.01: Equity Issuance
American Healthcare REIT established a $1.75 billion at-the-market equity offering program with BofA Securities, providing flexible capital-raising capacity for acquisitions and debt reduction.
Feb 27
8-K
American Healthcare REIT, Inc. -- 8-K Filing
American Healthcare REIT announced its fourth quarter 2025 results, with interim CEO Hanson signing the disclosure as the company reports financial performance through year-end.
Feb 26
8-K · 5.02
!!! Very High
American Healthcare REIT, Inc. -- 8-K 5.02: Executive Change
American Healthcare REIT appointed Jeffrey T. Hanson as Interim CEO effective February 3, 2026, signaling potential leadership transition amid ongoing management changes at the healthcare real estate company.
Feb 4
Data updated apr 24, 2026 4:43pm
· Source: massive.com